The EU has approved marketing of Kyleena (levonorgestrel-releasing intrauterine system) from Bayer HealthCare to prevent pregnancy. The product was approved...
Bayer HealthCare has successfully concluded the European registration procedure for its new low dose levonorgestrel-releasing intrauterine system (IUS) called Jaydress....
Bayer HealthCare Pharmaceuticals has submitted a New Drug Application (NDA) to the FDA seeking approval for LCS 16, an investigational...
Emergency contraception within 72 hours of unprotected sexual intercourse or failure of a contraceptive method.
Emergency contraception (EC) within 72 hours of unprotected sexual intercourse or failure of a contraceptive method. Levonorgestrel 1.5mg tablets are not recommended for use by young women under 16 years of age without medical supervision.
Emergency contraception within 72 hours of unprotected sexual intercourse or failure of a contraceptive method. Levonorgestrel is not recommended for use by young women under 16 years of age without medical supervision.
Allergan announced the launch of the new Liletta (levonorgestrel-releasing intrauterine system) 52 mg IUD single-handed inserter (intrauterine device), for use...
Emergency contraception within 72 hours of unprotected sexual intercourse or failure of a contraceptive method. Postinor is indicated in adults and adolescents >16 years of age.